BH
BioHarvest Sciences Inc.
BHST · NASDAQ
$1.62 +0.62% (+$0.01)
1M -20.49%
Market Cap $28.1M
P/E Ratio -
Div. Yield -
ROE 58.30%
Bulios Fair Price
$1.95
20.4% upside
Current Price
$1.62
Undervalued Fair Value Overvalued
According to Bulios Fair Price, BHST is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/B 1.42x
P/S 0.79x
EV/EBITDA N/A
Growth
100 /100
Growing Rev. growth 84.46%
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Net margin 31.21%
Op. margin 17.99%
FCF margin 30.87%
Quality
10 /100
Poor ROE 58.30%
ROA 24.84%
Asset turnover 0.80x
Debt
49 /100
Moderate Current ratio 2.24x
Int. coverage -1.71x
Debt/Equity 0.89x
Stability
32 /100
Unstable Rev. volatility 47.54%
EPS volatility 30.72%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BHST
Online
Sector
Industrials
Industry
Agricultural - Commodities/Milling
CEO
Zaki Rakib
Employees
89
Headquarters
Vancouver
Upcoming events
12 NOV
Earnings
Upcoming earnings report